Caseware UK (AP4) 2025.0.111 2025.0.111 Caseware UK (AP4) 2025.0.111 2025.0.111 2026-03-31837002025-04-012026-03-31falsenot blank00 04315313 2025-04-01 2026-03-31 04315313 2024-04-01 2025-03-31 04315313 2026-03-31 04315313 2025-03-31 04315313 2025-04-01 04315313 2024-04-01 04315313 c:RegisteredOffice 2025-04-01 2026-03-31 04315313 d:OfficeEquipment 2025-04-01 2026-03-31 04315313 d:OfficeEquipment 2026-03-31 04315313 d:OfficeEquipment 2025-03-31 04315313 d:CurrentFinancialInstruments 2026-03-31 04315313 d:CurrentFinancialInstruments 2025-03-31 04315313 c:FRS102 2025-04-01 2026-03-31 04315313 b:IndependentExaminationCharity 2025-04-01 2026-03-31 04315313 c:PrivateLimitedCompanyLtd 2025-04-01 2026-03-31 04315313 b:Trustee1 2025-04-01 2026-03-31 04315313 b:Trustee2 2025-04-01 2026-03-31 04315313 b:Trustee3 2025-04-01 2026-03-31 04315313 b:Trustee4 2025-04-01 2026-03-31 04315313 b:Trustee5 2025-04-01 2026-03-31 04315313 b:Trustee6 2025-04-01 2026-03-31 04315313 b:UnrestrictedFundsGeneral 2025-04-01 2026-03-31 04315313 b:UnrestrictedFundsGeneral 2024-04-01 2025-03-31 04315313 b:UnrestrictedFundsGeneral 2026-03-31 04315313 b:UnrestrictedFundsGeneral 2025-03-31 04315313 b:Activity1 2025-04-01 2026-03-31 04315313 b:Activity1 b:TotalUnrestrictedFunds 2025-04-01 2026-03-31 04315313 b:TotalUnrestrictedFunds 2026-03-31 04315313 b:TotalUnrestrictedFunds 2025-03-31 04315313 b:TotalRestrictedIncomeFunds 2026-03-31 04315313 b:TotalRestrictedIncomeFunds 2025-03-31 04315313 c:FullAccounts 2025-04-01 2026-03-31 iso4217:GBP xbrli:pure

Registered number: 04315313
Charity number: 1092448










BRITISH AUTOGENIC SOCIETY LIMITED
(A Company Limited by Guarantee)







UNAUDITED

TRUSTEES' REPORT AND FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 MARCH 2026

 
BRITISH AUTOGENIC SOCIETY LIMITED
 
(A Company Limited by Guarantee)
 

CONTENTS



Page
Reference and Administrative Details of the Company, its Trustees and Advisers
1
Trustees' Report
2 - 3
Independent Examiner's Report
4 - 5
Statement of Financial Activities
6
Balance Sheet
7 - 8
Notes to the Financial Statements
9 - 16

 
BRITISH AUTOGENIC SOCIETY LIMITED
 
(A Company Limited by Guarantee)
 

REFERENCE AND ADMINISTRATIVE DETAILS OF THE COMPANY, ITS TRUSTEES AND ADVISERS
FOR THE YEAR ENDED 31 MARCH 2026


Trustees
Jane Bird
Donna Flack
Dr Alison Stewart
Dr Linda Baines
Dr Nicholas Straiton
Dr Tracey Akins

Company registered number
04315313

Charity registered number
1092448

Registered office
International House
36-38 Cornhill
London
EC3V 3NG

Accountants
Kolade Andrew Alli ACMA
The ARK Financial Management Consultancy Ltd
10 Gatcombe Gardens
West End Hampshire
SO18 3NA

Page 1

 
BRITISH AUTOGENIC SOCIETY LIMITED
 
(A Company Limited by Guarantee)
 
  
TRUSTEES' REPORT
FOR THE YEAR ENDED 31 MARCH 2026

The Trustees present their annual report together with the financial statements of the British Autogenic Society Limited for the year 1 April 2025 to 31 March 2026The Annual Report serves the purposes of both a Trustees' report and a directors' report under company law. The Trustees confirm that the Annual Report and financial statements of the charitable company comply with the current statutory requirements, the requirements of the charitable company's governing document and the provisions of the Statement of Recommended Practice (SORP) applicable to charities preparing their accounts in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS102) (effective 1 January 2019). 
In setting objectives and planning for activities, the Trustees have given due consideration to general guidance published by the Charity Commission relating to public benefit, including the guidance 'Public benefit: running a charity (PB2)'.                                                                                                  
 

Achievements and performance
Income in 2025-26 has been from annual membership subscriptions and some donations. There was no new therapist training this year.

There are 37 full members, including 2 overseas, 6 retired and one student. 
Jade Flack continues as our administrator, for work on the website and general admin. Currently she works 3-4 hours per week. This has increased BAS outgoings, however the outlook will be good once we get social media platforms up and running. 
Plans for the future
The Charity will run a new PGCert-AT professional training course for therapists hopefully from September 2026. 

Joining the CPD certification Service
This is still under development. After approval of our training courses (personal and professional) the BAS will be promoted in this service, which is used by many professionals who constantly seek CPD (psychological / medical / educational and more) in their own domains. 
The purpose is to aid the BAS in its delivery of its aims (see above).  


                                                                                                                                               
 

Objectives and activities
 

Achievements and performance
 

Financial review
 

a. Going concern
 

After making appropriate enquiries, the Trustees have a reasonable expectation that the Company has adequate resources to continue in operational existence for the foreseeable future. For this reason, they continue to adopt the going concern basis in preparing the financial statements. Further details regarding the adoption of the going concern basis can be found in the accounting policies.
 

Structure, governance and management
 

a. Constitution
 

British Autogenic Society Limited is registered as a charitable company limited by guarantee and was set up by a Trust deed.
 

Page 2

 
BRITISH AUTOGENIC SOCIETY LIMITED
 
(A Company Limited by Guarantee)
 
Structure, governance and management (continued)

b. Methods of appointment or election of Trustees
 

The management of the Company is the responsibility of the Trustees who are elected and co-opted under the terms of the Trust deed.
 

Statement of Trustees' responsibilities
 

The Trustees (who are also the directors of the Company for the purposes of company law) are responsible for preparing the Trustees' Report and the financial statements in accordance with applicable law and United Kingdom Accounting Standards (United Kingdom Generally Accepted Accounting Practice).


Company law requires the Trustees to prepare financial statements for each financial year. Under company law, the Trustees must not approve the financial statements unless they are satisfied that they give a true and fair view of the state of affairs of the Company and of its incoming resources and application of resources, including its income and expenditure, for that period. In preparing these financial statements, the Trustees are required to:

select suitable accounting policies and then apply them consistently;
observe the methods and principles of the Charities SORP (FRS 102);
make judgments and accounting estimates that are reasonable and prudent;
state whether applicable UK Accounting Standards (FRS 102) have been followed, subject to any material departures disclosed and explained in the financial statements;
prepare the financial statements on the going concern basis unless it is inappropriate to presume that the Company will continue in business.


The Trustees are responsible for keeping adequate accounting records that are sufficient to show and explain the Company's transactions and disclose with reasonable accuracy at any time the financial position of the Company and enable them to ensure that the financial statements comply with the Companies Act 2006. They are also responsible for safeguarding the assets of the Company and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities.


 

Approved by order of the members of the board of Trustees on 4 July 2026 and signed on their behalf by:
 




Jane Bird
Page 3

 
BRITISH AUTOGENIC SOCIETY LIMITED

(A Company Limited by Guarantee)
 
 
 
INDEPENDENT EXAMINER'S REPORT
FOR THE YEAR ENDED 31 MARCH 2026

Independent Examiner's Report to the Trustees of British Autogenic Society Limited ('the Company')

 
I report to the charity Trustees on my examination of the accounts of the Company for the year ended 31 March 2026.


Responsibilities and Basis of Report


As the Trustees of the Company (and its directors for the purposes of company law) you are responsible for the preparation of the accounts in accordance with the requirements of the Companies Act 2006 ('the 2006 Act').


Having satisfied myself that the accounts of the Company are not required to be audited under Part 16 of the 2006 Act and are eligible for independent examination, I report in respect of my examination of the Company's accounts carried out under section 145 of the Charities Act 2011 ('the 2011 Act'). In carrying out my examination I have followed the Directions given by the Charity Commission under section 145(5)(b) of the 2011 Act.


Independent Examiner's Statement


I have completed my examination. I confirm that no matters have come to my attention in connection with the examination giving me cause to believe:


1.
accounting records were not kept in respect of the Company as required by section 386 of the 2006 Act; or

2.
the accounts do not accord with those records; or

3.
the accounts do not comply with the accounting requirements of section 396 of the 2006 Act other than any requirement that the accounts give a 'true and fair' view which is not a matter considered as part of an independent examination; or

4.
the accounts have not been prepared in accordance with the methods and principles of the Statement of Recommended Practice for accounting and reporting by charities [applicable to charities preparing their accounts in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102)].



I have no concerns and have come across no other matters in connection with the examination to which attention should be drawn in this report in order to enable a proper understanding of the accounts to be reached.


This report is made solely to the Company's Trustees, as a body, in accordance with Part 4 of the Charities (Accounts and Reports) Regulations 2008My work has been undertaken so that I might state to the Company's Trustees those matters I am required to state to them in an Independent Examiner's Report and for no other purpose. To the fullest extent permitted by law, I do not accept or assume responsibility to anyone other than the Company and the Company's Trustees as a body, for my work or for this report.





Signed:      Dated: 4 July 2026

 

 
Kolade Andrew Alli ACMA
 
The ARK Financial Management Consultancy Ltd
Page 4

 
BRITISH AUTOGENIC SOCIETY LIMITED

(A Company Limited by Guarantee)
 
 
 
INDEPENDENT EXAMINER'S REPORT (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2026


10 Gatcombe Gardens

West End Hampshire

SO18 3NA




Page 5

 
BRITISH AUTOGENIC SOCIETY LIMITED
 
(A Company Limited by Guarantee)

 
 
STATEMENT OF FINANCIAL ACTIVITIES (INCORPORATING INCOME AND EXPENDITURE ACCOUNT)
FOR THE YEAR ENDED 31 MARCH 2026


Unrestricted funds
2026
Total
funds
2026
Total
funds
2025
Note
        £
        £
        £

Income from:






Donations and legacies

2

392

392

5,534
 
Total income
392
392
5,534
Expenditure on:






Charitable activities

3

3,341

3,341

9,870
 
Total expenditure
3,341
3,341
9,870

Net movement in funds
  
(2,949)
(2,949)
(4,336)

Reconciliation of funds:

  




Total funds brought forward

  

41,850

41,850

46,186
 
Net movement in funds

  

(2,949)

(2,949)

(4,336)
 
Total funds carried forward
  
38,901
38,901
41,850

The Statement of Financial Activities includes all gains and losses recognised in the year.

The notes on pages 9 to 16 form part of these financial statements.

Page 6

 
BRITISH AUTOGENIC SOCIETY LIMITED
 
(A Company Limited by Guarantee)
REGISTERED NUMBER: 04315313

 
 
BALANCE SHEET
AS AT 31 MARCH 2026


2026
2025
Note
£
£

Fixed assets
  

Tangible assets
 6 
40
50

  
40
50

Current assets
  

Cash at bank and in hand
  
39,832
42,300

  
39,832
42,300

Current liabilities
  

Creditors: amounts falling due within one year
 7 
(971)
(500)

Net current assets 
  
 
 
38,861
 
 
41,800

Total assets less current liabilities
  
38,901
41,850

Net assets excluding pension asset 
  
38,901
41,850

Total net assets 
  
38,901
41,850


Charity funds
  

Restricted funds
 8 
-
-

Unrestricted funds
 8 
38,901
41,850

Total funds
  
38,901
41,850

The Company was entitled to exemption from audit under section 477 of the Companies Act 2006.

The members have not required the company to obtain an audit for the year in question in accordance with section 476 of Companies Act 2006.

The Trustees acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and preparation of financial statements.

The financial statements have been prepared in accordance with the provisions applicable to entities subject to the small companies regime.

The financial statements were approved and authorised for issue by the Trustees on 04 July 2026 and signed on their behalf by:

Page 7

 
BRITISH AUTOGENIC SOCIETY LIMITED
 
(A Company Limited by Guarantee)
REGISTERED NUMBER: 04315313

 
 
BALANCE SHEET (CONTINUED)
AS AT 31 MARCH 2026




Jane Bird

The notes on pages 9 to 16 form part of these financial statements.

Page 8

 
BRITISH AUTOGENIC SOCIETY LIMITED

(A Company Limited by Guarantee)
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2026

1.Accounting policies

  
1.1

Basis of preparation of financial statements

The financial statements have been prepared in accordance with the Charities SORP (FRS 102) - Accounting and Reporting by Charities: Statement of Recommended Practice applicable to charities preparing their accounts in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102) (effective 1 January 2019), the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102) and the Companies Act 2006.

British Autogenic Society Limited meets the definition of a public benefit entity under FRS 102. Assets and liabilities are initially recognised at historical cost or transaction value unless otherwise stated in the relevant accounting policy.

  
1.2

Income

All income is recognised once the Company has entitlement to the income, it is probable that the income will be received and the amount of income receivable can be measured reliably.

  
1.3

Expenditure

Expenditure is recognised once there is a legal or constructive obligation to transfer economic benefit to a third party, it is probable that a transfer of economic benefits will be required in settlement and the amount of the obligation can be measured reliably. Expenditure is classified by activity. The costs of each activity are made up of the total of direct costs and shared costs, including support costs involved in undertaking each activity. Direct costs attributable to a single activity are allocated directly to that activity. Shared costs which contribute to more than one activity and support costs which are not attributable to a single activity are apportioned between those activities on a basis consistent with the use of resources. Central staff costs are allocated on the basis of time spent, and depreciation charges allocated on the portion of the asset’s use.

Expenditure on charitable activities is incurred on directly undertaking the activities which further the Company's objectives, as well as any associated support costs.

All expenditure is inclusive of irrecoverable VAT.

 
1.4

Tangible fixed assets and depreciation

Tangible fixed assets costing £1,000 or more are capitalised and recognised when future economic benefits are probable and the cost or value of the asset can be measured reliably. 

Tangible fixed assets are initially recognised at cost. After recognition, under the cost model, tangible fixed assets are measured at cost less accumulated depreciation and any accumulated impairment losses. All costs incurred to bring a tangible fixed asset into its intended working condition should be included in the measurement of cost.

Depreciation is charged so as to allocate the cost of tangible fixed assets less their residual value over their estimated useful lives, .

Depreciation is provided on the following basis:

Office equipment
-
20%

Page 9

 
BRITISH AUTOGENIC SOCIETY LIMITED

(A Company Limited by Guarantee)
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2026

1.Accounting policies (continued)

  
1.5

Cash at bank and in hand

Cash at bank and in hand includes cash and short-term highly liquid investments with a short maturity of three months or less from the date of acquisition or opening of the deposit or similar account.


1.6

Liabilities and provisions

Liabilities are recognised when there is an obligation at the Balance Sheet date as a result of a past event, it is probable that a transfer of economic benefit will be required in settlement, and the amount of the settlement can be estimated reliably.

Liabilities are recognised at the amount that the Company anticipates it will pay to settle the debt or the amount it has received as advanced payments for the goods or services it must provide.

Provisions are measured at the best estimate of the amounts required to settle the obligation. Where the effect of the time value of money is material, the provision is based on the present value of those amounts, discounted at the pre-tax discount rate that reflects the risks specific to the liability. The unwinding of the discount is recognised in the Statement of Financial Activities as a finance cost.

  
1.7

Fund accounting

General funds are unrestricted funds which are available for use at the discretion of the Trustees in furtherance of the general objectives of the Company and which have not been designated for other purposes.

Page 10

 
BRITISH AUTOGENIC SOCIETY LIMITED

(A Company Limited by Guarantee)
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2026

2.

Income from donations and legacies




Unrestricted funds
2026
Total
funds
2026
Total
funds
2025
        £
        £
        £
 


 
Donations

392

392

5,534
 
Total 2025


5,534
5,534

Page 11

 
BRITISH AUTOGENIC SOCIETY LIMITED

(A Company Limited by Guarantee)
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2026

3.

Analysis of expenditure on charitable activities


Summary by fund type




Unrestricted funds
2026
Total
2026
Total
2025
        £
        £
        £




Direct costs - Activities (Activity 1)

3,341

3,341

9,870
 
Total 2025


9,870
9,870

Page 12

 
BRITISH AUTOGENIC SOCIETY LIMITED

(A Company Limited by Guarantee)
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2026

4.

Independent examiner's remuneration

2026
2025
£
£

Fees payable to the Company's independent examiner for the independent examination of the Company's annual accounts
600
500


5.


Trustees' remuneration and expenses

During the year, no Trustees received any remuneration or other benefits (2025 - £NIL).

During the year ended 31 March 2026, no Trustee expenses have been incurred (2025 - £NIL).


6.


Tangible fixed assets




Office equipment

£


Cost or valuation

At 1 April 2025
3,147


At 31 March 2026

3,147


Depreciation

At 1 April 2025
3,097

Charge for the year
10


At 31 March 2026

3,107


Net book value


At 31 March 2026
40


At 31 March 2025
50


7.



Creditors: Amounts falling due within one year


2026
2025
£
£


Other creditors
471
-

Accruals and deferred income
500
500
Page 13

 
BRITISH AUTOGENIC SOCIETY LIMITED

(A Company Limited by Guarantee)
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2026

7.Creditors: Amounts falling due within one year (continued)

2026
2025
£
£


971
500

Page 14

 
BRITISH AUTOGENIC SOCIETY LIMITED

(A Company Limited by Guarantee)
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2026

8.

Statement of funds


Statement of funds - current year

Balance at 1 April 2025
£
Income
£
Expenditure
£
Balance at 31 March 2026
£

Unrestricted funds





General Funds 

41,850

392

(3,341)

38,901
 

Page 15

 
BRITISH AUTOGENIC SOCIETY LIMITED

(A Company Limited by Guarantee)
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2026

8.

Statement of funds (continued)



Statement of funds - prior year

Balance at
1 April 2024
£
Income
£
Expenditure
£
Balance at
31 March 2025
£

Unrestricted funds





General Funds 

46,186

5,534

(9,870)

41,850
 




Page 16